Innovative GFAP blood biomarker test expands Labcorp's (LH) portfolio of tests for diseases including Alzheimer's disease, multiple sclerosis, glioblastoma and brain injuries BURLINGTON, N.C., April ...
Lumipulse® pTau-217/Beta Amyloid 42 Ratio now available nationwide through Labcorp BURLINGTON, N.C., Aug. 18, 2025 /PRNewswire/ -- Labcorp (NYSE: LH), a global leader of innovative and comprehensive ...
The complex health care fraud scheme involved billing for medically unnecessary tests and the payment of kickbacks to physicians in exchange for tests ordered by Labcorp, who denies all allegations.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback